Other Species / Isoforms
  AMPKB1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T4-p
____MGNtssERAAL
0 1
AMPKB1 (human) ____MGNtssERAAL T4-p
AMPKB1 (mouse) ____MGNTSSERAAL T4
AMPKB1 (rat) ____MGNTSSERAAL T4
S5-p
___MGNtssERAALE
0 1
AMPKB1 (human) ___MGNtssERAALE S5-p
AMPKB1 (mouse) ___MGNTSSERAALE S5
AMPKB1 (rat) ___MGNTSSERAALE S5
S6-p
__MGNtssERAALER
0 1
AMPKB1 (human) __MGNtssERAALER S6-p
AMPKB1 (mouse) __MGNTSSERAALER S6
AMPKB1 (rat) __MGNTSSERAALER S6
T19-p
ERHGGHKtPRRDssG
Upstream
0 24
Treatment
  • MG132_withdrawal
  • nocodazole
AMPKB1 (human) ERHGGHKtPRRDssG T19-p
AMPKB1 (mouse) ERQAGHKTPRRDsSG T19
AMPKB1 (rat) ERQAGHKTPRRDssG T19
S24-p
HKtPRRDssGGtKDG
Upstream
4 16
Kinase, in vitro:
  • AMPKA1 (human)
  • PKACA (human)
AMPKB1 (human) HKtPRRDssGGtKDG S24-p
AMPKB1 (mouse) HKTPRRDsSGGAKDG S24-p
AMPKB1 (rat) HKTPRRDssGGTKDG S24-p
S25-p
KtPRRDssGGtKDGD
3 4
AMPKB1 (human) KtPRRDssGGtKDGD S25-p
AMPKB1 (mouse) KTPRRDsSGGAKDGD S25
AMPKB1 (rat) KTPRRDssGGTKDGD S25-p
T28-p
RRDssGGtKDGDRPk
0 1
AMPKB1 (human) RRDssGGtKDGDRPk T28-p
AMPKB1 (mouse) RRDsSGGAKDGDRPK A28
AMPKB1 (rat) RRDssGGTKDGDRPK T28
K35-ub
tKDGDRPkILMDsPE
0 1
AMPKB1 (human) tKDGDRPkILMDsPE K35-ub
AMPKB1 (mouse) AKDGDRPKILMDsPE K35
AMPKB1 (rat) TKDGDRPKILMDsPE K35
S40-p
RPkILMDsPEDADLF
Upstream
0 16
Treatment
  • nocodazole
AMPKB1 (human) RPkILMDsPEDADLF S40-p
AMPKB1 (mouse) RPKILMDsPEDADIF S40-p
AMPKB1 (rat) RPKILMDsPEDADIF S40-p
S49-p
EDADLFHsEEIkAPE
0 2
AMPKB1 (human) EDADLFHsEEIkAPE S49-p
AMPKB1 (mouse) EDADIFHSEEIKAPE S49
AMPKB1 (rat) EDADIFHTEEMKAPE T49
K53-ub
LFHsEEIkAPEkEEF
0 1
AMPKB1 (human) LFHsEEIkAPEkEEF K53-ub
AMPKB1 (mouse) IFHSEEIKAPEKEEF K53
AMPKB1 (rat) IFHTEEMKAPEKEEF K53
K57-ub
EEIkAPEkEEFLAWQ
0 2
AMPKB1 (human) EEIkAPEkEEFLAWQ K57-ub
AMPKB1 (mouse) EEIKAPEKEEFLAWQ K57
AMPKB1 (rat) EEMKAPEKEEFLAWQ K57
K72-ub
HDLEVNDkAPAQARP
0 2
AMPKB1 (human) HDLEVNDkAPAQARP K72-ub
AMPKB1 (mouse) HDLEANDkAPAQARP K72-ub
AMPKB1 (rat) HDLEVNEKAPAQARP K72
T80-p
APAQARPtVFRWTGG
Upstream
1 0
Kinase, in vitro:
  • AMPKA1 (human)
AMPKB1 (human) APAQARPtVFRWTGG T80-p
AMPKB1 (mouse) APAQARPTVFRWTGG T80
AMPKB1 (rat) APAQARPTVFRWTGG T80
K89-ub
FRWTGGGkEVyLsGs
0 1
AMPKB1 (human) FRWTGGGkEVyLsGs K89-ub
AMPKB1 (mouse) FRWTGGGKEVYLSGs K89
AMPKB1 (rat) FRWTGGGKEVYLSGs K89
Y92-p
TGGGkEVyLsGsFNN
0 4
AMPKB1 (human) TGGGkEVyLsGsFNN Y92-p
AMPKB1 (mouse) TGGGKEVYLSGsFNN Y92
AMPKB1 (rat) TGGGKEVYLSGsFNN Y92
S94-p
GGkEVyLsGsFNNWs
0 1
AMPKB1 (human) GGkEVyLsGsFNNWs S94-p
AMPKB1 (mouse) GGKEVYLSGsFNNWs S94
AMPKB1 (rat) GGKEVYLSGsFNNWs S94
S96-p
kEVyLsGsFNNWskL
1 12
AMPKB1 (human) kEVyLsGsFNNWskL S96-p
AMPKB1 (mouse) KEVYLSGsFNNWsKL S96-p
AMPKB1 (rat) KEVYLSGsFNNWsKL S96-p
S101-p
sGsFNNWskLPLTRs
1 4
AMPKB1 (human) sGsFNNWskLPLTRs S101-p
AMPKB1 (mouse) SGsFNNWsKLPLtRs S101-p
AMPKB1 (rat) SGsFNNWsKLPLTRs S101-p
K102-ub
GsFNNWskLPLTRsH
0 2
AMPKB1 (human) GsFNNWskLPLTRsH K102-ub
AMPKB1 (mouse) GsFNNWsKLPLtRsQ K102
AMPKB1 (rat) GsFNNWsKLPLTRsQ K102
T106
NWskLPLTRsHNNFV
0 2
AMPKB1 (human) NWskLPLTRsHNNFV T106
AMPKB1 (mouse) NWsKLPLtRsQNNFV T106-p
AMPKB1 (rat) NWsKLPLTRsQNNFV T106
S108-p
skLPLTRsHNNFVAI
Upstream
Downstream
12 68
AMPKB1 (human)
S108-p
AMPKB1 (mouse)
S108-p
AMPKB1 (rat)
S108-p
Effects on Modified Protein
  • activity, induced
  • molecular association, regulation
  • phosphorylation
Kinase, in vitro:
  • AMPKA1 (human)
Treatment
  • angiotensin_2
  • antibody
  • cannabidiol
  • dasatinib
  • EGF
  • ionizing_radiation
  • ischemia
  • Lys05
  • metformin
  • nocodazole
  • SB202190
  • U0126
view more >
AMPKB1 (human) skLPLTRsHNNFVAI S108-p
AMPKB1 (mouse) sKLPLtRsQNNFVAI S108-p
AMPKB1 (rat) sKLPLTRsQNNFVAI S108-p
S138-p
GQWTHDPsEPIVTsQ
0 1
AMPKB1 (human) GQWTHDPsEPIVTsQ S138-p
AMPKB1 (mouse) GQWTHDPSEPIVTsQ S138
AMPKB1 (rat) GQWTHDPSEPIVTSQ S138
S144-p
PsEPIVTsQLGtVNN
0 3
AMPKB1 (human) PsEPIVTsQLGtVNN S144-p
AMPKB1 (mouse) PSEPIVTsQLGTVNN S144-p
AMPKB1 (rat) PSEPIVTSQLGTVNN S144
T148-p
IVTsQLGtVNNIIQV
Upstream
Downstream
1 3
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • AMPKA1 (human)
Treatment
  • A-769662
  • acadesine
  • glucose_starvation
  • insulin
  • oligomycin
  • phenformin
view more >
AMPKB1 (human) IVTsQLGtVNNIIQV T148-p
AMPKB1 (mouse) IVTsQLGTVNNIIQV T148
AMPKB1 (rat) IVTSQLGTVNNIIQV T148
K157-ub
NNIIQVKktDFEVFD
0 1
AMPKB1 (human) NNIIQVKktDFEVFD K157-ub
AMPKB1 (mouse) NNIIQVKKTDFEVFD K157
AMPKB1 (rat) NNIIQVKKTDFEVFD K157
T158-p
NIIQVKktDFEVFDA
Upstream
1 0
Kinase, in vitro:
  • AMPKA1 (human)
AMPKB1 (human) NIIQVKktDFEVFDA T158-p
AMPKB1 (mouse) NIIQVKKTDFEVFDA T158
AMPKB1 (rat) NIIQVKKTDFEVFDA T158
S170-p
FDALMVDsQKCsDVs
0 1
AMPKB1 (human) FDALMVDsQKCsDVs S170-p
AMPKB1 (mouse) FDALMVDSQKCsDVs S170
AMPKB1 (rat) FDALMVDSQKCSDVS S170
S174-p
MVDsQKCsDVsELss
Upstream
1 1
Kinase, in vitro:
  • AMPKA1 (human)
AMPKB1 (human) MVDsQKCsDVsELss S174-p
AMPKB1 (mouse) MVDSQKCsDVsELss S174-p
AMPKB1 (rat) MVDSQKCSDVSELSs S174
S177-p
sQKCsDVsELsssPP
Upstream
1 1
Kinase, in vitro:
  • AMPKA1 (human)
AMPKB1 (human) sQKCsDVsELsssPP S177-p
AMPKB1 (mouse) SQKCsDVsELsssPP S177-p
AMPKB1 (rat) SQKCSDVSELSssPP S177
S180-p
CsDVsELsssPPGPy
0 2
AMPKB1 (human) CsDVsELsssPPGPy S180-p
AMPKB1 (mouse) CsDVsELsssPPGPY S180-p
AMPKB1 (rat) CSDVSELSssPPGPY S180
S181-p
sDVsELsssPPGPyH
0 3
AMPKB1 (human) sDVsELsssPPGPyH S181-p
AMPKB1 (mouse) sDVsELsssPPGPYH S181-p
AMPKB1 (rat) SDVSELSssPPGPYH S181-p
S182-p
DVsELsssPPGPyHQ
Upstream
4 19
AMPKB1 (human)
S182-p
AMPKB1 (mouse)
S182-p
AMPKB1 (rat)
S182-p
Regulatory protein:
  • CD38 (human)
AMPKB1 (human) DVsELsssPPGPyHQ S182-p
AMPKB1 (mouse) DVsELsssPPGPYHQ S182-p
AMPKB1 (rat) DVSELSssPPGPYHQ S182-p
Y187-p
sssPPGPyHQEPYVC
0 8
AMPKB1 (human) sssPPGPyHQEPYVC Y187-p
AMPKB1 (mouse) sssPPGPYHQEPYMS Y187
AMPKB1 (rat) SssPPGPYHQEPYIS Y187
K195-ub
HQEPYVCkPEERFRA
0 2
AMPKB1 (human) HQEPYVCkPEERFRA K195-ub
AMPKB1 (mouse) HQEPYMSKPEERFKA K195
AMPKB1 (rat) HQEPYISKPEERFKA K195
Y240
HVMLNHLYALSIKDG
0 1
AMPKB1 (human) HVMLNHLYALSIKDG Y240
AMPKB1 (mouse) HVMLNHLyALSIKDG Y240-p
AMPKB1 (rat) HVMLNHLYALSIKDG Y240
T254-p
GVMVLSAtHRYKKKy
0 1
AMPKB1 (human) GVMVLSAtHRYKKKy T254-p
AMPKB1 (mouse) GVMVLSATHRYKKKy T254
AMPKB1 (rat) GVMVLSATHRYKKKY T254
Y261-p
tHRYKKKyVTTLLYk
0 7
AMPKB1 (human) tHRYKKKyVTTLLYk Y261-p
AMPKB1 (mouse) THRYKKKyVTTLLYK Y261-p
AMPKB1 (rat) THRYKKKYVTTLLYK Y261
K268-ub
yVTTLLYkPI_____
0 1
AMPKB1 (human) yVTTLLYkPI_____ K268-ub
AMPKB1 (mouse) yVTTLLYKPI_____ K268
AMPKB1 (rat) YVTTLLYKPI_____ K268